Figure 4
From: Dantrolene is neuroprotective in Huntington's disease transgenic mouse model
Dantrolene feeding improves gait abnormalities in YAC128 mice. Gait analysis of WT and YAC128 mice in dantrolene trial. (A). The footprint patterns of 13.5-month-old WT and YAC128 for control and dantrolene groups are shown. (B) Stride lengths (cm) and (C) front/hind footprint overlaps (cm) of WT and YAC128 mice in dantrolene trial are shown as mean ± SE (n = number of mice (10) in each groupsee Table 2), *p < 0.05 using one-way ANOVA with Tukey's post test. WT, wild type; YAC, YAC128; Ctrl, control; Dan, dantrolene.